Sunshine Biopharma (SBFM) Change in Account Payables (2010 - 2019)
Sunshine Biopharma's (SBFM) quarterly Change in Account Payables came in at $33797.0 in Q4 2019, down 19.32% YoY from $41891.0 in Q4 2018, and up 260.63% on a QoQ basis from -$21040.0 in Q3 2019.
Sunshine Biopharma (SBFM) Change in Account Payables (2010 - 2019) Analysis & Trends
Sunshine Biopharma (SBFM) has 10 years of Change in Account Payables data on file, last reported at $33797.0 in Q4 2019.
- Quarterly Change in Account Payables fell 19.32% year-over-year to $33797.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$18692.0 (down 151.21% YoY) and the FY2020 annual result came in at -$35012.0, down 87.31% from the prior year.
- Change in Account Payables grew to $33797.0 in Q4 2019, from -$21040.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $342944.0 in Q2 2017 to a low of -$359099.0 in Q3 2017.
- A 5-year average of -$3273.6 and a median of -$171.0 in 2017 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2018 — Change in Account Payables sank 6587.13% — and 2019, when it surged 18113.93%.
- Tracing SBFM's Change in Account Payables over 5 years: stood at $11953.0 in 2015, then jumped by 132.57% to $27799.0 in 2016, then sank by 41.27% to $16326.0 in 2017, then jumped by 156.59% to $41891.0 in 2018, then decreased by 19.32% to $33797.0 in 2019.
- The last three Change in Account Payables figures came in at $33797.0 (Q4 2019), -$21040.0 (Q3 2019), and $21977.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sunshine Biopharma | 1.60 Mn | -12.15 Mn | 2.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 33,797.00 |
| Dec 31, 2019 | 33,797.00 |
| Sep 30, 2019 | -21,040.00 |
| Sep 30, 2019 | -21,040.00 |
| Jun 30, 2019 | 21,977.00 |
| Jun 30, 2019 | 21,977.00 |
| Mar 31, 2019 | -53,426.00 |
| Mar 31, 2019 | -53,426.00 |
| Dec 31, 2018 | 41,891.00 |
| Dec 31, 2018 | 41,891.00 |
| Sep 30, 2018 | 6,166.00 |
| Sep 30, 2018 | 6,166.00 |
| Jun 30, 2018 | -122.00 |
| Jun 30, 2018 | -122.00 |
| Mar 31, 2018 | -11,435.00 |
| Mar 31, 2018 | -11,435.00 |
| Dec 31, 2017 | 16,326.00 |
| Dec 31, 2017 | 16,326.00 |
| Sep 30, 2017 | -359,099.00 |
| Sep 30, 2017 | -359,099.00 |